FrostPharma is an entrepreneurial Swedish pharmaceutical company specializing in the commercialization of value-adding medicines and healthcare consumables, for which there is a specific and well-defined need.
Since the start in 2017, FrostPharma has successfully commercialized a broad range of products across multiple disease areas throughout the Nordic region and the Baltics. Key to this success has been the ability to match specific patient and health care needs with relevant products, in combination with the in-house expertise in sales and marketing to quickly generate sales.
FrostPharma has around 30 employees and is headquartered in Stockholm.
Members of the Board
Rolf Classon (Chairman of the Board), Christer Ahlberg, Clas Lindbergson, Eva Walde, Karl-Johan Willén, Louise Nilsson
Priveq team
Karl-Johan Willén, Louise Nilsson, Daniel Nylund
Karl-Johan Willén
Partner & Investment Manager
Phone: +46 8 459 67 66
Mobile: +46 70 950 88 25
Email: karljohan.willen@priveq.se
